NewsPronto

 
The Times


.

ACN Newswire

Read more press releases from ACN Newswire here

The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab

  • Written by ACN Newswire

image

Paris, France and Cambridge, Massachusetts, USA, Apr 11, 2018 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that it will cooperate with The University of Texas MD Anderson Cancer Center, Houston TX, to work on...

Read more: The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run...